{"id":"W2897963283","doi":"10.1093/annonc/mdy292.082","title":"Biopsy on progression in EGFR mutation positive (EGFRm) advanced non-small cell lung cancer (aNSCLC) patients (pts): A Canadian experience","year":2018,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency; University of British Columbia; AstraZeneca (Canada); University of Alberta","funders":"","keywords":"Medicine; Osimertinib; T790M; Lung cancer; Biopsy; Internal medicine; Cancer; Oncology; Erlotinib; ROS1; Adenocarcinoma; Epidermal growth factor receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001397625,0.0002885966,0.000287893,0.0005946199,0.001245794,0.0006942075,0.0005192893,0.0002976547,0.001739163],"category_scores_gemma":[0.002144574,0.0002046628,0.0002319475,0.001313382,0.0007102377,0.0002142725,0.0006198933,0.0006239634,0.0002227496],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.006040618,"about_ca_system_score_gemma":0.01087636,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.7070248,"about_ca_topic_score_gemma":0.8182047,"domain_scores_codex":[0.9993328,0.0001403993,0.00003300145,0.00009356346,0.0002984509,0.0001017066],"domain_scores_gemma":[0.99828,0.0001530371,0.0001808758,0.00006766356,0.0008067631,0.0005116769],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002692922,0.0004758213,0.8511028,0.0004253123,0.000116114,0.003684695,0.002459411,0.0003401183,0.006624426,0.0002165563,0.003457009,0.1284048],"study_design_scores_gemma":[0.00009052906,0.001393642,0.9821517,0.00009931168,0.00008626308,0.005014101,0.001590914,0.0003665284,0.001018449,0.00004925098,0.008117535,0.00002176007],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9876081,0.004401439,0.0004335396,0.0003685518,0.00003161055,0.0004252004,0.0007673783,0.00001619956,0.005948103],"genre_scores_gemma":[0.9933089,0.004117953,0.0007829059,0.0002270673,0.00002147177,0.00003422294,0.0005732288,0.000008615546,0.0009255715],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2929752,"threshold_uncertainty_score":0.5894011,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02488979194502366,"score_gpt":0.4191821325137499,"score_spread":0.3942923405687262,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}